Vertex (VRTX) Slumps on VX-809 Data Presentation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Vertex (VRTX) Slumps on VX-809 Data Presentation

Analyst Says Vertex (VRTX) Drug Data Shows "At Least Moderate Impact"

October 12, 2012 8:29 AM EDT

Vertex Pharmaceuticals (Nasdaq: VRTX) presented additional data from cohort 2 of the Phase 2 VX-809 (lumacaftor/ivacaftor) trial in F508del cystic fibrosis patients at the NACFC meeting yesterday.

Commenting on the data, analyst Alan Carr of Needham and Company said "Although interpretation... More